Chemical Name64Cu-DOTATATE
Dosage FormInjection (intravenous; 148 MBq (4 mCi), 37 MBq (1 mCi) per 1 mL)
Drug ClassRadioactive diagnostic agents
CompanyCurium US LLC
Approval Year2020


  • For detection of the specific type of tumors called somatostatin receptor positive neuro-endocrine tumors (NETs) in adults.
Last updated on 12/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Detectnet (copper Cu 64 dotatate injection) Prescribing Information. 2020Curium US LLC., Maryland Heights, MO